secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001193125-23-154245
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics shareholders approve 1-for-10 reverse stock split and elect directors at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved 1-for-10 reverse stock split: 22.3M votes for, 4.0M against.
- Margaret McLoughlin and Una Ryan elected as Class I directors with over 8.1M votes each.
- Ratification of BDO USA as auditor for FY2023 approved with 22.9M votes for.
- Advisory vote on executive compensation passed with 8.7M votes for, 2.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523154245/0001193125-23-154245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312523154245/d367319d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-154245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer